DM

David Moebius

AM Amgen: 5 patents #645 of 2,867Top 25%
OT Onyx Therapeutics: 5 patents #11 of 49Top 25%
CY Cytokinetics: 4 patents #58 of 199Top 30%
Harvard University: 1 patents #1,740 of 3,600Top 50%
SP Syros Pharmaceuticals: 1 patents #39 of 53Top 75%
Overall (All Time): #408,142 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11780826 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2023-10-10
11299479 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2022-04-12
11078233 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2021-08-03
11040981 Pyrrolotriazine compounds and methods of inhibiting TAM kinases Jason J. Marineau, Yi Zhang, Claudio Edmundo Chuaqui, Goran Malojcic, William Sinko +6 more 2021-06-22
10899746 Bisamide sarcomere activating compounds and uses thereof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2021-01-26
10723720 Bisamide sarcomere activating compounds and uses therof Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more 2020-07-28
10689367 Triazole pyridyl compounds as agonists of the APJ receptor Yinhong Chen, Alan C. Cheng, Mikkel V. Debenedetto, Paul John Dransfield, James S. Harvey +8 more 2020-06-23
10647744 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2020-05-12
RE47302 Peptide epoxyketone immunoproteasome inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2019-03-19
9657057 Dipeptide and tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson 2017-05-23
9434761 Tripeptide epoxy ketone protease inhibitors Dustin McMinn, Henry Johnson, Simeon Bowers 2016-09-06
9321713 Hyperforin analogs, methods of synthesis, and uses thereof Matthew D. Shair, Brian Andrew Sparling 2016-04-26